Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine. Macdonell R, Nagels G, Laplaud D-A, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, et al. Mult Scler. 2015 Oct 7. PMID: 26447066. Abstract CommentRecommendBookmarkWatch